---
title: "CKLIFE SCIENCES issued a profit warning, expecting a mid-term loss attributable to shareholders of approximately HKD 150 million, a year-on-year turnaround from profit to loss"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/250966881.md"
description: "According to the announcement from CKLIFE SCIENCES, the group expects to incur a shareholder loss of approximately HKD 150 million for the six months ending June 30, 2025, compared to a shareholder profit of HKD 1 million in the same period of 2024. The shift from profit to loss is attributed to the company's earlier decision to increase R&D investment. Overall, the group's operations have remained stable during the reporting period and up to the date of this announcement"
datetime: "2025-07-31T10:15:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250966881.md)
  - [en](https://longbridge.com/en/news/250966881.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250966881.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/250966881.md) | [繁體中文](https://longbridge.com/zh-HK/news/250966881.md)


# CKLIFE SCIENCES issued a profit warning, expecting a mid-term loss attributable to shareholders of approximately HKD 150 million, a year-on-year turnaround from profit to loss

According to the announcement from CKLIFE SCIENCES (00775), the group expects to incur a shareholder's attributable loss of approximately HKD 150 million for the six months ending June 30, 2025, compared to a shareholder's attributable profit of HKD 1 million for the same period in 2024. The shift from profit to loss is attributed to the company's earlier decision to increase research and development investment. Overall, the group's operations have remained stable during the reporting period and up to the date of this announcement

### 相关股票

- [CKLIFE SCIENCES (00775.HK)](https://longbridge.com/zh-CN/quote/00775.HK.md)

## 相关资讯与研究

- [CK Life Sciences Forms New Unit to Advance Cancer Vaccine Research](https://longbridge.com/zh-CN/news/278525401.md)
- [Tommy DeCarlo, lead singer of Boston, dies at 60](https://longbridge.com/zh-CN/news/278537939.md)
- [Japan PM Takaichi cancels official duties over suspected cold symptoms, Jiji reports](https://longbridge.com/zh-CN/news/278859414.md)
- [Fosun Pharmaceutical Unit Gets Clinical Trial Approval for Cancer Drug](https://longbridge.com/zh-CN/news/278501201.md)
- [15:05 ETPreeclampsia Foundation Announces Major Maternal Health Initiative at HHS National Conference on Women's Health](https://longbridge.com/zh-CN/news/278930854.md)